A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming

Padraic Fallon, Takashi Sasaki, Aileen Sandilands, Linda Campbell, Sean Saunders, Niamh Mangan, John Callanan, Hiroshi Kawasaki, Aiko Shiohama, Akiharu Kubo, John Sundberg, Richard Presland, Philip Fleckman, Nobuyoshi Shimizu, Jun Kudoh, Alan Irvine, Masayuki Amagai, W H McLean

Research output: Contribution to journalArticleResearchpeer-review

379 Citations (Scopus)


Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris and convey major genetic risk for atopic dermatitis (eczema), eczema-associated asthma and other allergic phenotypes. Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of approximately 9 in Europe. Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.
Original languageEnglish
Pages (from-to)602 - 608
Number of pages7
JournalNature Genetics
Issue number5
Publication statusPublished - 2009
Externally publishedYes

Cite this